Trial intelligence / Profile preview

Pilot study of intravenous lidocaine and dexamethasone on inflammatory response after breast cancer surgery

2012-002222-70Phase 4Completed

Sponsor
Radboud University Medical Center
Start
Aug 2013
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
Countries
1
01

Overview

Phase 4 trial of lidocaine and dexamethasone in breast cancer and postoperative pain, sponsored by Radboud University Medical Center. Primary endpoint: Change in cytokine levels (IL-1β, IL-6, IL-10, IL-1Ra). Started Aug 2013; status: completed.

02

Drugs

lidocainedexamethasone
03

Conditions

breast cancerpostoperative pain

Beyond the preview

Go deeper on 2012-002222-70.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2012-002222-70.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call